Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Free Cash Flow Generation Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Free Cash Flow Generation Index of 0.95x as of June 2025. Free cash flow of CN¥347.08 Million represents 1% of operating cash flow (CN¥367.02 Million). See Zhejiang Jolly Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Explore Zhejiang Jolly Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jolly Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Zhejiang Jolly Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | CN¥124.66 Million | CN¥411.80 Million | CN¥287.14 Million | ▲ +163.2% |
| 2024 | 0.11x | CN¥34.16 Million | CN¥297.05 Million | CN¥262.89 Million | ▼ -78.8% |
| 2023 | 0.54x | CN¥156.75 Million | CN¥288.46 Million | CN¥131.71 Million | ▲ +23.2% |
| 2022 | 0.44x | CN¥140.56 Million | CN¥318.59 Million | CN¥178.03 Million | ▲ +7.0% |
| 2021 | 0.41x | CN¥103.84 Million | CN¥251.80 Million | CN¥147.95 Million | ▼ -47.9% |
| 2020 | 0.79x | CN¥221.34 Million | CN¥279.69 Million | CN¥58.35 Million | ▲ +15.3% |
| 2019 | 0.69x | CN¥88.48 Million | CN¥128.94 Million | CN¥40.46 Million | ▲ +171.0% |
| 2018 | -0.97x | CN¥-75.64 Million | CN¥78.28 Million | CN¥153.92 Million | ▲ +94.7% |
| 2017 | -18.12x | CN¥-117.89 Million | CN¥6.51 Million | CN¥124.40 Million | ▼ -1143.8% |
| 2016 | -1.46x | CN¥-84.94 Million | CN¥58.30 Million | CN¥143.24 Million | ▼ -299.2% |
| 2015 | 0.73x | CN¥71.04 Million | CN¥97.13 Million | CN¥26.08 Million | ▲ +139.1% |
| 2014 | -1.87x | CN¥-25.60 Million | CN¥13.70 Million | CN¥39.30 Million | ▼ -1055.4% |
| 2013 | 0.20x | CN¥5.77 Million | CN¥29.50 Million | CN¥23.73 Million | ▲ +191.3% |
| 2012 | -0.21x | CN¥-6.54 Million | CN¥30.51 Million | CN¥37.05 Million | ▲ +93.9% |
| 2011 | -3.49x | CN¥-47.67 Million | CN¥13.65 Million | CN¥61.32 Million | ▼ -966.6% |
| 2010 | 0.40x | CN¥26.10 Million | CN¥64.78 Million | CN¥38.68 Million | ▼ -27.2% |
| 2009 | 0.55x | CN¥24.30 Million | CN¥43.89 Million | CN¥19.60 Million | ▼ -7.6% |
| 2008 | 0.60x | CN¥18.66 Million | CN¥31.16 Million | CN¥12.50 Million | ▲ +38.7% |
| 2007 | 0.43x | CN¥6.93 Million | CN¥16.05 Million | CN¥9.12 Million | — |